Care.com Inc (NYSE:CRCM) Expected to Post Quarterly Sales of $52.23 Million

Equities analysts forecast that Care.com Inc (NYSE:CRCM) will post $52.23 million in sales for the current fiscal quarter, Zacks Investment Research reports. Three analysts have provided estimates for Care.com’s earnings, with estimates ranging from $52.20 million to $52.28 million. Care.com posted sales of $49.16 million during the same quarter last year, which would indicate a positive year over year growth rate of 6.2%. The company is expected to report its next quarterly earnings report on Thursday, November 14th.

According to Zacks, analysts expect that Care.com will report full year sales of $207.20 million for the current year, with estimates ranging from $207.02 million to $207.37 million. For the next fiscal year, analysts anticipate that the business will post sales of $223.90 million, with estimates ranging from $222.80 million to $226.03 million. Zacks’ sales calculations are an average based on a survey of research analysts that that provide coverage for Care.com.

Care.com (NYSE:CRCM) last announced its earnings results on Tuesday, August 6th. The information services provider reported $0.09 earnings per share for the quarter, beating the consensus estimate of $0.08 by $0.01. Care.com had a positive return on equity of 7.81% and a negative net margin of 7.61%. The firm had revenue of $51.00 million for the quarter, compared to the consensus estimate of $52.20 million. During the same quarter in the previous year, the business earned $0.14 EPS. The firm’s revenue for the quarter was up 10.9% on a year-over-year basis.

A number of analysts have recently commented on CRCM shares. ValuEngine raised Care.com from a “sell” rating to a “hold” rating in a research note on Thursday, August 1st. Stifel Nicolaus reissued a “hold” rating and issued a $17.00 price objective on shares of Care.com in a research note on Thursday, May 9th. Zacks Investment Research downgraded Care.com from a “buy” rating to a “hold” rating in a research note on Monday. BTIG Research raised Care.com from a “neutral” rating to a “buy” rating and set a $13.00 price objective on the stock in a research note on Wednesday. Finally, Craig Hallum reissued a “hold” rating and issued a $9.00 price objective (down previously from $15.00) on shares of Care.com in a research note on Wednesday, August 7th. Five analysts have rated the stock with a hold rating and one has issued a buy rating to the company’s stock. The company currently has an average rating of “Hold” and a consensus target price of $12.20.

In other news, insider David Krupinski sold 3,052 shares of the business’s stock in a transaction on Tuesday, June 11th. The stock was sold at an average price of $14.37, for a total transaction of $43,857.24. Following the sale, the insider now directly owns 152,303 shares of the company’s stock, valued at $2,188,594.11. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CEO Sheila Lirio Marcelo sold 9,805 shares of the business’s stock in a transaction on Tuesday, June 11th. The stock was sold at an average price of $14.37, for a total value of $140,897.85. Following the sale, the chief executive officer now directly owns 1,221,974 shares in the company, valued at $17,559,766.38. The disclosure for this sale can be found here. Insiders have sold 21,273 shares of company stock worth $305,693 over the last ninety days. 28.10% of the stock is owned by insiders.

Several institutional investors have recently made changes to their positions in CRCM. Cloverdale Capital Management LLC acquired a new stake in shares of Care.com during the second quarter worth $10,365,000. Renaissance Technologies LLC grew its holdings in shares of Care.com by 17.6% during the second quarter. Renaissance Technologies LLC now owns 2,386,200 shares of the information services provider’s stock valued at $26,200,000 after buying an additional 357,500 shares in the last quarter. JPMorgan Chase & Co. grew its holdings in shares of Care.com by 5,040.1% during the second quarter. JPMorgan Chase & Co. now owns 249,964 shares of the information services provider’s stock valued at $2,749,000 after buying an additional 245,101 shares in the last quarter. D. E. Shaw & Co. Inc. grew its holdings in shares of Care.com by 136.3% during the second quarter. D. E. Shaw & Co. Inc. now owns 423,405 shares of the information services provider’s stock valued at $4,649,000 after buying an additional 244,188 shares in the last quarter. Finally, Dimensional Fund Advisors LP grew its holdings in shares of Care.com by 100.6% during the fourth quarter. Dimensional Fund Advisors LP now owns 423,460 shares of the information services provider’s stock valued at $8,177,000 after buying an additional 212,393 shares in the last quarter. 85.99% of the stock is currently owned by institutional investors.

Shares of CRCM traded up $0.72 during midday trading on Thursday, reaching $10.06. The stock had a trading volume of 1,256,357 shares, compared to its average volume of 574,409. Care.com has a 52 week low of $7.61 and a 52 week high of $25.81. The company has a debt-to-equity ratio of 0.20, a current ratio of 2.85 and a quick ratio of 2.85. The firm’s 50 day moving average price is $10.64 and its 200-day moving average price is $16.33. The company has a market capitalization of $298.16 million, a P/E ratio of 27.94, a P/E/G ratio of 121.33 and a beta of 0.92.

About Care.com

Care.com, Inc operates an online marketplace for finding and managing family care in the United States and internationally. The company helps families to address their lifecycle of care needs, including child care, senior care, and special needs care, as well as other non-medical family care needs, such as pet care, tutoring, and housekeeping; and enables caregivers to find full-time and part-time employment opportunities.

Featured Story: Calculating net profit and net profit margin ratio

Get a free copy of the Zacks research report on Care.com (CRCM)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Care.com Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Care.com and related companies with MarketBeat.com's FREE daily email newsletter.